TrialDiabetes care2003

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

Anthony Keech et al.PubMed ↗Publisher ↗

No numbers read from the abstract.